Response to 'The importance of immunosuppression as risk and prognostic factor for periorbital non-melanoma skin cancers'
Eye (Lond)
.
2018 Jan;32(1):160-161.
doi: 10.1038/eye.2017.171.
Epub 2017 Aug 25.
Authors
R C Gerring
1
,
C T Ott
1
,
J M Curry
1
,
Z B Sargi
1
,
S T Wester
1
Affiliation
1
Division of Oculoplastic Surgery, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
PMID:
28840856
PMCID:
PMC5770715
DOI:
10.1038/eye.2017.171
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Basal Cell*
Humans
Prognosis
Risk Factors
Skin Neoplasms*